| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |